Concept Medical’s manufacturing arm has reduced its carbon footprint via in-house efficiency improvement programmes & green infrastructure
The Indian pharmaceutical industry includes a network of 3,000 drug companies and 10,500 manufacturing units. It is projected to reach a value of US$ 130 billion by 2030
The additional $50 million will go towards venture capital firms that specialize in near- and long-term healthcare solutions for patients in low- and middle-income countries
Wider reach for nutraceuticals portfolio in Europe, Turkey and Egypt
‘Fibrotic disease’ is a term that covers a range of diseases characterized by uncontrolled and progressive fibrosis,
Biopharma can benefit from the critical enablers of innovation in the private healthcare system in India
Pheezee is designed to assess musculoskeletal and neuromuscular health.
The planned bioprocessing facility would support commercial manufacturing for biotech and pharmaceutical customers across Asia-Pacific.
The partnership will capitalize on the combined capabilities of the two organizations
The policymakers, doctors and, patient bodies discuss ways to implement thalassemia control programme nationally
Subscribe To Our Newsletter & Stay Updated
